Lactated Ringers injection, also known as Hartmann's solution, is an electrolyte-containing solution commonly used for fluid and electrolyte replacement in surgical settings or illnesses involving loss of fluid. It contains sodium, potassium, calcium, chloride and lactate ions to replenish essential electrolytes in ill patients. Lactated Ringers injection is administered intravenously through infusion to treat dehydration, blood pressure issues, shock, burns or other illnesses resulting in fluid/electrolyte imbalance. The global demand for intravenous solutions continues augmenting with the rising incidence of chronic diseases like cancer, cardiovascular conditions, gastrointestinal disorders and trauma cases that often lead to electrolyte deficiencies and fluid loss requiring IV supplementation.

The global lactated ringers injection market is estimated to be valued at USD 541.3 Mn in 2025 and is expected to reach USD 819.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032. 
Key Takeaways

Key players operating in the Lactated Ringers Injection market are Baxter, B. Braun Melsungen AG, ICU Medical Inc.

Growing demand in the market: The prevalence of chronic conditions continue rising worldwide. As per WHO estimates, cancer burden is expected to climb by about 70% over the next two decades. With therapies like chemotherapy, surgery and mechanical ventilation commonly used in chronic illnesses, the need for IV fluid therapy is rising in tandem. This is anticipated to drive volumes in Lactated Ringers Injection Market Demand.

Get More Insights On- Lactated Ringers Injection Market